| 0024-5840 |
ZALTRAP |
ziv-aflibercept |
sanofi-aventis U.S. LLC |
SOLUTION, CONCENTRATE |
|
2012-08-03 |
| 0024-5841 |
ZALTRAP |
ziv-aflibercept |
sanofi-aventis U.S. LLC |
SOLUTION, CONCENTRATE |
|
2012-08-03 |
| 0069-0315 |
Zirabev |
bevacizumab-bvzr |
Pfizer Laboratories Div Pfizer Inc |
INJECTION, SOLUTION |
|
2020-01-13 |
| 0069-0342 |
Zirabev |
bevacizumab-bvzr |
Pfizer Laboratories Div Pfizer Inc |
INJECTION, SOLUTION |
|
2020-01-13 |
| 50242-060 |
Avastin |
bevacizumab |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2004-02-26 |
| 50242-061 |
Avastin |
bevacizumab |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2004-02-26 |
| 50242-078 |
Susvimo |
Ranibizumab |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2021-10-22 |
| 50242-080 |
LUCENTIS |
RANIBIZUMAB |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2006-06-30 |
| 50242-082 |
LUCENTIS |
RANIBIZUMAB |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2012-08-10 |
| 55513-056 |
PAVBLU |
aflibercept-ayyh |
Amgen, Inc |
INJECTION, SOLUTION |
|
2024-10-28 |
| 55513-065 |
PAVBLU |
aflibercept-ayyh |
Amgen, Inc |
INJECTION, SOLUTION |
|
2024-10-28 |
| 55513-206 |
MVASI |
bevacizumab-awwb |
Amgen Inc |
INJECTION, SOLUTION |
|
2018-06-01 |
| 55513-207 |
MVASI |
bevacizumab-awwb |
Amgen Inc |
INJECTION, SOLUTION |
|
2018-06-01 |
| 61314-624 |
CIMERLI |
ranibizumab-eqrn |
Sandoz Inc |
INJECTION, SOLUTION |
|
2024-12-12 |
| 61314-625 |
CIMERLI |
ranibizumab-eqrn |
Sandoz Inc |
INJECTION, SOLUTION |
|
2024-12-12 |
| 61755-005 |
EYLEA |
aflibercept |
Regeneron Pharmaceuticals, Inc. |
INJECTION, SOLUTION |
|
2011-11-21 |
| 61755-050 |
EYLEA HD |
aflibercept |
Regeneron Pharmaceuticals, Inc |
INJECTION, SOLUTION |
|
2023-08-18 |
| 61755-051 |
EYLEA HD |
aflibercept |
Regeneron Pharmaceuticals, Inc |
INJECTION, SOLUTION |
|
2023-08-18 |
| 64406-019 |
Byooviz |
ranibizumab-nuna |
BIOGEN INC. |
INJECTION, SOLUTION |
|
2022-06-01 |
| 70114-440 |
CIMERLI |
ranibizumab-eqrn |
Coherus BioSciences Inc |
INJECTION, SOLUTION |
|
2022-10-03 |
| 70114-441 |
CIMERLI |
ranibizumab-eqrn |
Coherus BioSciences Inc |
INJECTION, SOLUTION |
|
2022-10-03 |
| 70121-1754 |
ALYMSYS |
bevacizumab-maly |
Amneal Pharmaceuticals LLC |
INJECTION, SOLUTION |
|
2022-04-15 |
| 70121-1755 |
ALYMSYS |
bevacizumab-maly |
Amneal Pharmaceuticals LLC |
INJECTION, SOLUTION |
|
2022-04-15 |
| 72606-011 |
Vegzelma |
bevacizumab-adcd |
CELLTRION USA, Inc. |
INJECTION, SOLUTION |
|
2023-04-03 |
| 72606-012 |
Vegzelma |
bevacizumab-adcd |
CELLTRION USA, Inc. |
INJECTION, SOLUTION |
|
2023-04-03 |
| 83257-009 |
JOBEVNE |
bevacizumab-nwgd |
Biocon Biologics Inc. |
INJECTION |
|
2025-04-10 |
| 83257-010 |
JOBEVNE |
bevacizumab-nwgd |
Biocon Biologics Inc. |
INJECTION |
|
2025-04-10 |